Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Structural Transitions in Nanosized Zn0.97Al0.03O Powders under High Pressure Analyzed by in Situ Angle-Dispersive X-ray Diffraction.

Lin CM, Liu HT, Zhong SY, Hsu CH, Chiu YT, Tai MF, Juang JY, Chuang YC, Liao YF.

Materials (Basel). 2016 Jul 12;9(7). pii: E561. doi: 10.3390/ma9070561.

2.
3.

Lower Levels of Urinary Nerve Growth Factor Might Predict Recurrent Urinary Tract Infections in Women.

Chuang FC, Liu HT, Kuo HC.

Int Neurourol J. 2016 Mar;20(1):33-9. doi: 10.5213/inj.1630454.227. Epub 2016 Mar 15.

4.
5.
6.

Urothelial dysfunction and chronic inflammation in patients with spinal cord injuries at different levels and correlation with urodynamic findings.

Jiang YH, Liu HT, Kuo HC.

Neurourol Urodyn. 2015 Nov;34(8):757-62. doi: 10.1002/nau.22650. Epub 2014 Jul 25.

PMID:
25065363
7.
8.

Overactive bladder changes with time: a 5-year longitudinal followup of changes in overactive bladder symptoms, urodynamic studies and urinary nerve growth factor levels.

Chuang FC, Liu HT, Wang LY, Kuo HC.

J Urol. 2014 Aug;192(2):458-63. doi: 10.1016/j.juro.2014.02.091. Epub 2014 Mar 2.

PMID:
24594404
9.

Pilot study of liposome-encapsulated onabotulinumtoxina for patients with overactive bladder: a single-center study.

Kuo HC, Liu HT, Chuang YC, Birder LA, Chancellor MB.

Eur Urol. 2014 Jun;65(6):1117-24. doi: 10.1016/j.eururo.2014.01.036. Epub 2014 Feb 11.

PMID:
24555904
10.

Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.

Jiang YH, Peng CH, Liu HT, Kuo HC.

PLoS One. 2013 Oct 17;8(10):e76779. doi: 10.1371/journal.pone.0076779. eCollection 2013.

11.

Increased serum adipokines implicate chronic inflammation in the pathogenesis of overactive bladder syndrome refractory to antimuscarinic therapy.

Liu HT, Jiang YH, Kuo HC.

PLoS One. 2013 Oct 1;8(10):e76706. doi: 10.1371/journal.pone.0076706. eCollection 2013.

12.

Effect of alanine replacement of l17 and f19 on the aggregation and neurotoxicity of arctic-type aβ40.

Chen YR, Huang HB, Lo CJ, Wang CC, Ho LK, Liu HT, Shiao MS, Lin TH, Chen YC.

PLoS One. 2013 Apr 25;8(4):e61874. doi: 10.1371/journal.pone.0061874. Print 2013.

13.
14.
15.

Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.

Liu HT, Shie JH, Chen SH, Wang YS, Kuo HC.

Urology. 2012 Jul;80(1):225.e13-8. doi: 10.1016/j.urology.2012.01.047. Epub 2012 Apr 21.

PMID:
22521193
16.

Increased cell apoptosis of urothelium mediated by inflammation in interstitial cystitis/painful bladder syndrome.

Shie JH, Liu HT, Kuo HC.

Urology. 2012 Feb;79(2):484.e7-13. doi: 10.1016/j.urology.2011.09.049.

PMID:
22310775
17.

Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.

Liu HT, Lin H, Kuo HC.

Neurourol Urodyn. 2011 Nov;30(8):1525-9. doi: 10.1002/nau.21118. Epub 2011 Aug 8.

PMID:
21826717
18.

Promise of Urinary Nerve Growth Factor for Assessment of Overactive Bladder Syndrome.

Kuo HC, Liu HT, Guan Z, Tyagi P, Chancellor MB.

Low Urin Tract Symptoms. 2011 Apr;3(1):2-9. doi: 10.1111/j.1757-5672.2011.00087.x. Epub 2011 Feb 9.

PMID:
26676344
19.

Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder.

Chung SD, Liu HT, Lin H, Kuo HC.

Neurourol Urodyn. 2011 Mar;30(3):417-20. doi: 10.1002/nau.20938. Epub 2011 Jan 31.

PMID:
21284020
20.

Aβ40(L17A/F19A) mutant diminishes the aggregation and neurotoxicity of Aβ40.

Chen YR, Huang HB, Lo CJ, Wang CC, Su CL, Liu HT, Shiao MS, Lin TH, Chen YC.

Biochem Biophys Res Commun. 2011 Feb 4;405(1):91-5. doi: 10.1016/j.bbrc.2010.12.133. Epub 2011 Jan 7.

PMID:
21216230

Supplemental Content

Loading ...
Support Center